Simard John bought 70,000 shares of XBiotech Inc. at $2.05 for $143k on Nov 3, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Director
DIR
Filed Nov 13, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$143,409Shares × reported price
Shares traded
70,000Common Stock
Price per share
$2.05Reported price. Read footnotes for ranges.
% of reported position traded
1.67%This security and ownership context
Holdings after
4,261,690Direct
Trade date
Nov 3, 2026Buy
Filed
Nov 13, 2026, 3:49 PM ET10-day reporting delay
Accession
0001193125-26-460514Code P · Transaction 400461
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 4,191,690 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 10 calendar days after the transaction date.

XBIT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
XBIT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 20, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago1w ago1d ago −2%
Returns since7d30d90d180d1y

Footnotes in full

No footnotes recorded. Check the original SEC filing for the complete report.